These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35421421)

  • 1. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
    Ravindran A; Kurtin PJ; King RL; Yuan J; Feldman AL; Rech KL; McPhail ED; Parikh SA; Ding W; Shi M
    Hum Pathol; 2022 Jul; 125():2-10. PubMed ID: 35421421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma.
    Lyapichev KA; Sakhdari A; Khoury JD; O'Malley DP; El Hussein S; Yin CC; Patel KP; Thakral B; Young KH; Medeiros LJ; Konoplev S
    Ann Diagn Pathol; 2020 Dec; 49():151636. PubMed ID: 32977233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
    Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
    Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
    Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
    Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
    Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canonical and non-canonical Wnt signal pathway in classic Hodgkin lymphoma and the prognostic significance of LEF1, β-catenin, FZD6 and Wnt5a/b.
    Gao L; Cui W; Kelting S; Woodroof J; Li H; Li L; Zhang D
    Am J Blood Res; 2022; 12(4):136-143. PubMed ID: 36147604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Xia D; Sayed S; Moloo Z; Gakinya SM; Mutuiri A; Wawire J; Okiro P; Courville EL; Hasserjian RP; Sohani AR
    Am J Clin Pathol; 2022 Feb; 157(2):231-243. PubMed ID: 34542569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.
    Wlodarska I; Nooyen P; Maes B; Martin-Subero JI; Siebert R; Pauwels P; De Wolf-Peeters C; Hagemeijer A
    Blood; 2003 Jan; 101(2):706-10. PubMed ID: 12393409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
    Liso A; Capello D; Marafioti T; Tiacci E; Cerri M; Distler V; Paulli M; Carbone A; Delsol G; Campo E; Pileri S; Pasqualucci L; Gaidano G; Falini B
    Blood; 2006 Aug; 108(3):1013-20. PubMed ID: 16614247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
    Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
    Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional characterization of LEF1 expression in nodular lymphocyte predominant Hodgkin lymphoma and classic Hodgkin lymphoma.
    Rea B; Bailey NG
    Ann Diagn Pathol; 2021 Jun; 52():151730. PubMed ID: 33743303
    [No Abstract]   [Full Text] [Related]  

  • 19. Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.
    Linke F; Harenberg M; Nietert MM; Zaunig S; von Bonin F; Arlt A; Szczepanowski M; Weich HA; Lutz S; Dullin C; Janovská P; Krafčíková M; Trantírek L; Ovesná P; Klapper W; Beissbarth T; Alves F; Bryja V; Trümper L; Wilting J; Kube D
    Leukemia; 2017 Feb; 31(2):361-372. PubMed ID: 27535218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma.
    Gerhard-Hartmann E; Jöhrens K; Schinagl LM; Zamó A; Rosenwald A; Anagnostopoulos I; Rosenfeldt M
    Histopathology; 2022 Jun; 80(7):1071-1080. PubMed ID: 35322462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.